| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accidental HPV vaccination in pregnancy: no adverse effects
|
Balakrishnan, Vijay Shankar
|
|
2017
|
18 |
5 |
p. e251
|
artikel
|
| 2 |
American Association for Cancer Research Annual Meeting 2017
|
Sklan, Alexandra
|
|
2017
|
18 |
5 |
p. 579-580
|
artikel
|
| 3 |
Avelumab, an anti-PD-L1 monoclonal antibody, shows activity in various tumour types
|
Kotsakis, Athanasios
|
|
2017
|
18 |
5 |
p. 556-557
|
artikel
|
| 4 |
Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial
|
Heery, Christopher R
|
|
2017
|
18 |
5 |
p. 587-598
|
artikel
|
| 5 |
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial
|
Gulley, James L
|
|
2017
|
18 |
5 |
p. 599-610
|
artikel
|
| 6 |
Beauties of the Night
|
Swain, Kelley
|
|
2017
|
18 |
5 |
p. 585
|
artikel
|
| 7 |
Cancer risk paradox: grand plans fall short?
|
The Lancet Oncology,
|
|
2017
|
18 |
5 |
p. 555
|
artikel
|
| 8 |
Carcinogenicity of welding, molybdenum trioxide, and indium tin oxide
|
Guha, Neela
|
|
2017
|
18 |
5 |
p. 581-582
|
artikel
|
| 9 |
Chemotherapy for advanced urothelial cancer: end of the beginning?
|
Dreicer, Robert
|
|
2017
|
18 |
5 |
p. 567-569
|
artikel
|
| 10 |
Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial
|
Alley, Evan W
|
|
2017
|
18 |
5 |
p. 623-630
|
artikel
|
| 11 |
Correction to Lancet Oncol 2017; 18: e186
|
|
|
2017
|
18 |
5 |
p. e245
|
artikel
|
| 12 |
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
|
Sahm, Felix
|
|
2017
|
18 |
5 |
p. 682-694
|
artikel
|
| 13 |
Embracing certainty
|
Thorley, Jennifer
|
|
2017
|
18 |
5 |
p. 586
|
artikel
|
| 14 |
Engaging specialist oncologists in the assessment of oncology drugs in Canada
|
Evans, William Kenneth
|
|
2017
|
18 |
5 |
p. 573-575
|
artikel
|
| 15 |
Epigenetics: a new tool for meningioma management?
|
Sanson, Marc
|
|
2017
|
18 |
5 |
p. 569-570
|
artikel
|
| 16 |
Escalated anthracycline dose in adult AML
|
Balakrishnan, Vijay Shankar
|
|
2017
|
18 |
5 |
p. e253
|
artikel
|
| 17 |
Genomic biomarkers for precision radiation medicine
|
Bratman, Scott V
|
|
2017
|
18 |
5 |
p. e238
|
artikel
|
| 18 |
Genomic biomarkers for precision radiation medicine – Authors' reply
|
Scott, Jacob G
|
|
2017
|
18 |
5 |
p. e239
|
artikel
|
| 19 |
Good Life, Good Death
|
Burki, Talha Khan
|
|
2017
|
18 |
5 |
p. 583-584
|
artikel
|
| 20 |
Immune-checkpoint inhibition for digestive cancers
|
Manfredi, Sylvain
|
|
2017
|
18 |
5 |
p. 561-562
|
artikel
|
| 21 |
Immune checkpoint inhibitors in malignant pleural mesothelioma
|
Ceresoli, Giovanni Luca
|
|
2017
|
18 |
5 |
p. 559-561
|
artikel
|
| 22 |
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
|
Ascierto, Paolo A
|
|
2017
|
18 |
5 |
p. 611-622
|
artikel
|
| 23 |
Laparoscopic and abdominal hysterectomy are equivalent
|
Burki, Talha Khan
|
|
2017
|
18 |
5 |
p. e250
|
artikel
|
| 24 |
Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial
|
García-Donas, Jesus
|
|
2017
|
18 |
5 |
p. 672-681, 681a
|
artikel
|
| 25 |
Management of elderly patients with locoregionally confined head and neck cancer
|
Porceddu, Sandro V
|
|
2017
|
18 |
5 |
p. e274-e283
|
artikel
|
| 26 |
Mid-face bone destruction involving the palate
|
Almoznino, Galit
|
|
2017
|
18 |
5 |
p. e290
|
artikel
|
| 27 |
Molecular diagnoses of century-old childhood tumours
|
Virasami, Alex
|
|
2017
|
18 |
5 |
p. e237
|
artikel
|
| 28 |
Monoclonal antibody YS110 for refractory solid tumours
|
Das, Manjulika
|
|
2017
|
18 |
5 |
p. e247
|
artikel
|
| 29 |
New NICE criteria for drug access
|
Fricker, Janet
|
|
2017
|
18 |
5 |
p. 576
|
artikel
|
| 30 |
Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial
|
Kudo, Toshihiro
|
|
2017
|
18 |
5 |
p. 631-639
|
artikel
|
| 31 |
Ongoing drugs shortage in Venezuela and effects on cancer care
|
Burki, Talha Khan
|
|
2017
|
18 |
5 |
p. 578
|
artikel
|
| 32 |
Optimum dosing of ipilimumab in melanoma: too little, too late?
|
Menzies, Alexander M
|
|
2017
|
18 |
5 |
p. 558-559
|
artikel
|
| 33 |
Pembrolizumab in advanced head and neck cancer
|
Brower, Vicki
|
|
2017
|
18 |
5 |
p. e248
|
artikel
|
| 34 |
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma
|
Wu, Junyan
|
|
2017
|
18 |
5 |
p. e241-e242
|
artikel
|
| 35 |
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma
|
Ku, Geoffrey
|
|
2017
|
18 |
5 |
p. e243
|
artikel
|
| 36 |
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma – Authors' reply
|
Smyth, Elizabeth C
|
|
2017
|
18 |
5 |
p. e244
|
artikel
|
| 37 |
Poorly specified fasting conditions in clinical research could lead to treatment failure
|
Lubberman, Floor J E
|
|
2017
|
18 |
5 |
p. 571-573
|
artikel
|
| 38 |
Potential for low-value palliative care of patients with recurrent head and neck cancer
|
Nilsen, Marci L
|
|
2017
|
18 |
5 |
p. e284-e289
|
artikel
|
| 39 |
Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial
|
Rugo, Hope S
|
|
2017
|
18 |
5 |
p. 654-662
|
artikel
|
| 40 |
Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial
|
Takahashi, Toshiaki
|
|
2017
|
18 |
5 |
p. 663-671
|
artikel
|
| 41 |
Proposed US Government budget cuts would ‘devastate’ cancer research
|
Furlow, Bryant
|
|
2017
|
18 |
5 |
p. 577
|
artikel
|
| 42 |
Proton therapy for head and neck cancer: expanding the therapeutic window
|
Leeman, Jonathan E
|
|
2017
|
18 |
5 |
p. e254-e265
|
artikel
|
| 43 |
Quality of life after treatments for prostate cancer
|
Venkatesan, Priya
|
|
2017
|
18 |
5 |
p. e249
|
artikel
|
| 44 |
Sacituzumab govitecan activity in advanced breast cancer
|
Burki, Talha Khan
|
|
2017
|
18 |
5 |
p. e246
|
artikel
|
| 45 |
Sentinel-lymph-node mapping in endometrial cancer
|
Gorostidi, Mikel
|
|
2017
|
18 |
5 |
p. e235
|
artikel
|
| 46 |
Sentinel-lymph-node mapping in endometrial cancer
|
Bogani, Giorgio
|
|
2017
|
18 |
5 |
p. e234
|
artikel
|
| 47 |
Sentinel-lymph-node mapping in endometrial cancer – Authors' reply
|
Rossi, Emma C
|
|
2017
|
18 |
5 |
p. e236
|
artikel
|
| 48 |
Stem cell transplantation in multiple myeloma
|
Das, Manjulika
|
|
2017
|
18 |
5 |
p. e252
|
artikel
|
| 49 |
SWISH-ing steroids: new standard of care to prevent everolimus-induced oral mucositis?
|
Spring, Laura
|
|
2017
|
18 |
5 |
p. 564-565
|
artikel
|
| 50 |
Targeting HER2 beyond progression in gastroesophageal cancer
|
Sanoff, Hanna K
|
|
2017
|
18 |
5 |
p. 562-564
|
artikel
|
| 51 |
The future of personalised radiotherapy for head and neck cancer
|
Caudell, Jimmy J
|
|
2017
|
18 |
5 |
p. e266-e273
|
artikel
|
| 52 |
The Hero
|
Kinsey, Caroline
|
|
2017
|
18 |
5 |
p. 584
|
artikel
|
| 53 |
Time to reconsider prophylactic cranial irradiation in extensive-stage small-cell lung cancer?
|
Slotman, Ben J
|
|
2017
|
18 |
5 |
p. 566-567
|
artikel
|
| 54 |
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
|
Thuss-Patience, Peter C
|
|
2017
|
18 |
5 |
p. 640-653
|
artikel
|
| 55 |
Treating head and neck cancer: for better or for worse?
|
Sklan, Alex
|
|
2017
|
18 |
5 |
p. 570-571
|
artikel
|
| 56 |
Why Am I Not a Butterfly?
|
Mariotti, Laura
|
|
2017
|
18 |
5 |
p. 583
|
artikel
|
| 57 |
Widening the gap: additional concerns with crowdfunding in health care
|
Snyder, Jeremy
|
|
2017
|
18 |
5 |
p. e240
|
artikel
|
Tijdschrift beschrijving